The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.

Inflamm Res · 2021 · PMC8479713 · PMID 34586459

Europe PMC DOI

hedged sentence

0.1507

closest p · 3.0× alpha

0.1507

boldest claim

The sentences

did not reach statistical significanceP = 0.1507not close (p > 0.1)

There was a trend to a longer fever in patients who received rescue therapy compared to patients who received the IP only, but the differences did not reach statistical significance ( P = 0.1507).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.